MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss
-$32,968K
(14.60%↑ Y/Y)
Gain before income
taxes
-$32,968K
Product revenues, net
$20,033K
(15.11%↑ Y/Y)
License revenues and
royalties
$818K
(-85.47%↓ Y/Y)
Loss from operations
-$25,245K
(11.31%↑ Y/Y)
Total other expense,
net
-$7,723K
(22.56%↑ Y/Y)
Total revenue, net
$20,851K
(-9.47%↓ Y/Y)
Other, net
$2,632K
(1196.55%↑ Y/Y)
Interest income
$1,994K
(-2.92%↓ Y/Y)
Total operating
expense
$46,096K
(-10.49%↓ Y/Y)
Interest expense
$12,349K
(0.97%↑ Y/Y)
Research and development
$19,877K
(-31.29%↓ Y/Y)
Selling and marketing
$12,708K
(20.42%↑ Y/Y)
General and
administrative
$9,896K
(-0.59%↓ Y/Y)
Cost of product sales
$3,615K
(75.40%↑ Y/Y)
Deferred royalty
obligation interest...
$8,727K
(3.34%↑ Y/Y)
Effective interest
expense on senior...
$3,622K
(-4.31%↓ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
ADC Therapeutics SA (ADCT)
ADC Therapeutics SA (ADCT)